Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity

The aim of this study was to identify prognostic markers of complications in patients with severe COVID-19, focusing on comorbidities such as hypertension, coronary artery disease, and diabetes. The study was conducted on 189 patients in tertiary hospitals and divided patients into four groups based...

Full description

Saved in:
Bibliographic Details
Main Authors: Khidoyatova Mukhlisa, Nabieva Dildora, Muxammadieva Sevara, Yakupova Svetlana
Format: Article
Language:English
Published: EDP Sciences 2025-01-01
Series:BIO Web of Conferences
Online Access:https://www.bio-conferences.org/articles/bioconf/pdf/2025/02/bioconf_mblc2024_04032.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832098672499752960
author Khidoyatova Mukhlisa
Nabieva Dildora
Muxammadieva Sevara
Yakupova Svetlana
author_facet Khidoyatova Mukhlisa
Nabieva Dildora
Muxammadieva Sevara
Yakupova Svetlana
author_sort Khidoyatova Mukhlisa
collection DOAJ
description The aim of this study was to identify prognostic markers of complications in patients with severe COVID-19, focusing on comorbidities such as hypertension, coronary artery disease, and diabetes. The study was conducted on 189 patients in tertiary hospitals and divided patients into four groups based on the presence of comorbidities. The major complications identified included acute respiratory distress syndrome (ARDS), pulmonary embolism, and atrial fibrillation, which were more common in patients with two or more comorbidities. The study found that comorbidities significantly impacted mortality, with ARDS affecting 29.7% of patients. The results suggest the need for targeted interventions for high-risk patients, especially those with cardiovascular disease and obesity, to improve COVID-19 outcomes.
format Article
id doaj-art-0fe38e9f43df419781306bff09b77ac9
institution Kabale University
issn 2117-4458
language English
publishDate 2025-01-01
publisher EDP Sciences
record_format Article
series BIO Web of Conferences
spelling doaj-art-0fe38e9f43df419781306bff09b77ac92025-02-05T10:42:42ZengEDP SciencesBIO Web of Conferences2117-44582025-01-011510403210.1051/bioconf/202515104032bioconf_mblc2024_04032Complications and Adverse Covid-19 Outcomes on Patients with ComorbidityKhidoyatova Mukhlisa0Nabieva Dildora1Muxammadieva Sevara2Yakupova Svetlana3Tashkent Medical AcademyTashkent Medical AcademyTashkent Medical AcademyKazan State University of the Ministry of Health of RussiaThe aim of this study was to identify prognostic markers of complications in patients with severe COVID-19, focusing on comorbidities such as hypertension, coronary artery disease, and diabetes. The study was conducted on 189 patients in tertiary hospitals and divided patients into four groups based on the presence of comorbidities. The major complications identified included acute respiratory distress syndrome (ARDS), pulmonary embolism, and atrial fibrillation, which were more common in patients with two or more comorbidities. The study found that comorbidities significantly impacted mortality, with ARDS affecting 29.7% of patients. The results suggest the need for targeted interventions for high-risk patients, especially those with cardiovascular disease and obesity, to improve COVID-19 outcomes.https://www.bio-conferences.org/articles/bioconf/pdf/2025/02/bioconf_mblc2024_04032.pdf
spellingShingle Khidoyatova Mukhlisa
Nabieva Dildora
Muxammadieva Sevara
Yakupova Svetlana
Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity
BIO Web of Conferences
title Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity
title_full Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity
title_fullStr Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity
title_full_unstemmed Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity
title_short Complications and Adverse Covid-19 Outcomes on Patients with Comorbidity
title_sort complications and adverse covid 19 outcomes on patients with comorbidity
url https://www.bio-conferences.org/articles/bioconf/pdf/2025/02/bioconf_mblc2024_04032.pdf
work_keys_str_mv AT khidoyatovamukhlisa complicationsandadversecovid19outcomesonpatientswithcomorbidity
AT nabievadildora complicationsandadversecovid19outcomesonpatientswithcomorbidity
AT muxammadievasevara complicationsandadversecovid19outcomesonpatientswithcomorbidity
AT yakupovasvetlana complicationsandadversecovid19outcomesonpatientswithcomorbidity